BELLA WELLNESS
DEAD

Serial Number

90510587

Owner

LivePerson, Inc.

Attorney

Kimberly S. Grimsley

Filing Date

Feb 4, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BELLA WELLNESS Trademark

Serial Number: 90510587

BELLA WELLNESS is a trademark filed by LivePerson, Inc. on February 4, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

LivePerson, Inc. (177 trademarks)

665 Broadway, Suite 1200
New York, NY 10012

Entity Type: 03

Trademark Details

Filing Date

February 4, 2021

Registration Date

Not Registered

Published for Opposition

April 12, 2022

Goods & Services

Downloadable computer application software for mobile phones, namely, software for covid-19 and other infectious disease identification; Downloadable computer application software for computers, namely, software for covid-19 and other infectious disease identification; Downloadable mobile applications for health screenings relating to COVID-19 and other infectious disease; Downloadable mobile applications for tracking and reporting health conditions and symptoms; Scientific apparatus and instruments, namely, COVID-19 rapid tests for withdrawing and testing respiratory droplets for clinical and medical research, and scientific purposes and structural parts and fittings thereof; Material testing apparatus and instruments, for identifying and testing pathogens and biomarkers in respiratory droplets for clinical, medical, research, and scientific purposes related to COVID-19 and other infectious diseases; Apparatus for transmission of communication; Monitoring, measuring, signaling and control apparatus and instruments for testing respiratory droplets against a panel of biomarkers for clinical, medical, research, and scientific purposes, namely, for COVID-19 and other infectious diseases

Diagnostic kits comprised of medical diagnostic assays for use in disease detection, screening, treating and monitoring, namely, monitoring COVID-19 and other infectious diseases; Respiratory diagnostic rapid tests, namely, assays for use in performing respiratory rapid tests related to COVID-19 and other infectious diseases; Medical diagnostic screening tests and devices being assays to detect COVID-19 and other infectious diseases in a patient

Information collection and management services in the field of public health, namely, collecting, verifying, tracing, tracking, storing, monitoring, and notifying physical sites visited by persons infected with contagious disease for the purpose of slowing or stopping the spread of the disease under the guidance of state and local public health departments; Information collection and management services in the field of public health, namely, collecting, verifying, tracing, tracking, storing, monitoring, and notifying contacts of persons infected with contagious disease for the purpose of slowing or stopping the spread of the disease under the guidance of state and local public health departments

Healthcare services; Medical and healthcare information, consultancy and advisory services relating to infections, viruses, SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Providing a web site featuring medical information; Health care services, namely, disease management programs; Telehealth services, namely, providing telemedicine and services in conjunction with providing medical and healthcare services; Mobile healthcare services in the field of Covid and other infectious disease testing, health assessments, intravenous infusion therapy, facilitating appointments

Providing temporary use of online non-downloadable software for use in the testing and diagnosis of COVID-19, coronavirus, and other diseases; Providing temporary use of online non-downloadable software for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms; Providing temporary use of web-based software applications for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms; Software as a service (SAAS) services featuring software for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 10, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 10, 2023 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 19, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 19, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 19, 2023 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 1, 2022 EXRA
SOU EXTENSION 1 GRANTED
Nov 29, 2022 EX1G
SOU EXTENSION 1 FILED
Nov 29, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 29, 2022 EEXT
ASSIGNED TO EXAMINER
Nov 16, 2022 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 7, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 12, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 12, 2022 PUBO
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 8, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 8, 2022 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 8, 2022 COAR
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 23, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 7, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 2, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 1, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 1, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 2, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 2, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 2, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 2, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 8, 2021 NWOS
NEW APPLICATION ENTERED
Feb 8, 2021 NWAP